0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Clinical Crossroads | Clinician's Corner

A 66-Year-Old Man With Sexual Dysfunction

Abraham Morgentaler, MD, Discussant
JAMA. 2004;291(24):2994-3003. doi:10.1001/jama.291.24.2994.
Text Size: A A A
Published online

Extract

DR BURNS: Mr G is a 66-year-old man with a history of hypertension and sleep apnea. He lives in a suburb of Boston with his wife and has commercial indemnity insurance.

Mr G first developed erectile dysfunction (ED) several years ago. Four months ago when he saw his primary care physician for a routine checkup, he asked about using sildenafil (Viagra). He noted decreased libido and difficulty attaining an erection. He had slight urinary urgency, but no difficulty initiating urination. He had no history of diabetes or cardiovascular disease. In the past, he had used a dental device to treat his sleep apnea but was no longer using one. His other past medical history was a colonic adenoma found on a screening colonoscopy in 2001. His medications were aspirin (81 mg daily), hydrochlorothiazide (12.5 mg daily), and ibuprofen (600 mg 4 times a day as needed). His wife had metastatic breast cancer and was doing well with maintenance therapy. He was working part-time and noted considerable stress due to a home renovation project.

Figures in this Article

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Figure. Mechanism of Erection and Sites of Action of Various Treatment Modalities for Erectile Dysfunction
Graphic Jump Location
Penile erection is achieved through relaxation of smooth muscle cells lining arterial vessels and sinusoidal spaces in the corpora cavernosa, which leads to increased arterial inflow and pressure, decreased venous outflow, and increased intracavernosal pressure. Smooth muscle relaxation is mediated by intracellular generation of cyclic guanosine monophosphate (GMP) from guanosine triphosphate (GTP) via activation of guanylate cyclase by nitric oxide. Treatment modalities for erectile dysfunction (shown in blue) include oral phosphodiesterase type 5 (PDE 5) inhibitors, which inhibit the breakdown of cyclic GMP, and local vasoactive agents. A link between testosterone and nitric oxide synthase has been demonstrated experimentally,83 but the significance of this observation in humans has not been established (indicated by dashed line and question mark). Psychotherapy (not shown) may also be effective in selected individuals with erectile dysfunction.

Tables

References

Letters

CME


You need to register in order to view this quiz.
Submit a Response

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles
Sexual function in chronic kidney disease. Adv Chronic Kidney Dis 2007;14(2):119-25.
Jobs
brightcove.createExperiences();